{"transactions":[{"id":940727,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T19:05:32.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":2.01,"expiration_date":"2036-01-09","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-26-002978","document":"tm262917d4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465926002978/tm262917d4_4seq1.xml","form_type":"4"}},{"id":1482923,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T19:02:07.000Z","date":"2024-06-10","kind":"other","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ.  The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.44,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-24-070518","document":"tm2416928-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465924070518/tm2416928-5_4seq1.xml","form_type":"4"}},{"id":1482922,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T19:02:07.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ.  The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":1.44,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-24-070518","document":"tm2416928-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465924070518/tm2416928-5_4seq1.xml","form_type":"4"}},{"id":1842487,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-28T16:56:21.000Z","date":"2023-06-26","kind":"other","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ.  The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":17.52,"expiration_date":"2033-06-26","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-23-075863","document":"tm2319786-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465923075863/tm2319786-3_4seq1.xml","form_type":"4"}},{"id":1842486,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-28T16:56:21.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ.  The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":17.52,"expiration_date":"2033-06-26","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-23-075863","document":"tm2319786-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465923075863/tm2319786-3_4seq1.xml","form_type":"4"}},{"id":2259369,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T18:48:59.000Z","date":"2022-05-19","kind":"other","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":13.24,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-22-063971","document":"tm2216669-2_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465922063971/tm2216669-2_4seq.xml","form_type":"4"}},{"id":2259368,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T18:48:59.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":13.24,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-22-063971","document":"tm2216669-2_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465922063971/tm2216669-2_4seq.xml","form_type":"4"}},{"id":2667556,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-15T17:36:45.000Z","date":"2021-06-11","kind":"other","acquired":false,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full and become exercisable on the earlier of the first anniversary of the grant date or the day immediately prior to the date of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":37.86,"expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001104659-21-081588","document":"tm2119762-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465921081588/tm2119762-2_4seq1.xml","form_type":"4"}},{"id":2667555,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-15T17:36:45.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full and become exercisable on the earlier of the first anniversary of the grant date or the day immediately prior to the date of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":14500,"derivative":{"exercise_price":37.86,"expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001104659-21-081588","document":"tm2119762-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465921081588/tm2119762-2_4seq1.xml","form_type":"4"}},{"id":3134650,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-26T16:17:09.000Z","date":"2020-05-21","kind":"other","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ.  The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full and become exercisable on the earlier of the first anniversary of the grant date or the day immediately prior to the date of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":49.74,"expiration_date":"2030-05-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-065871","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465920065871/a4.xml","form_type":"4"}},{"id":3134649,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-26T16:17:09.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ.  The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full and become exercisable on the earlier of the first anniversary of the grant date or the day immediately prior to the date of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":49.74,"expiration_date":"2030-05-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-065871","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465920065871/a4.xml","form_type":"4"}},{"id":3483654,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T21:07:14.000Z","date":"2019-05-23","kind":"other","acquired":false,"shares":4700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ.  The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full and become exercisable on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":10.04,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":4700},"source":{"system":"sec-edgar","filing":"0001104659-19-036496","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465919036496/a4.xml","form_type":"4"}},{"id":3483653,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T21:07:14.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":4700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ.  The Reporting Person does not beneficially own any of the securities reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full and become exercisable on the first anniversary of the grant date."}],"balance_after":4700,"derivative":{"exercise_price":10.04,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":4700},"source":{"system":"sec-edgar","filing":"0001104659-19-036496","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465919036496/a4.xml","form_type":"4"}},{"id":3589975,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-03-18T17:38:14.000Z","date":"2019-03-07","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":7.91,"value":79100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option vest as follows: one-third on each of 3/7/2020, 3/7/2021 and 3/7/2022, subject to the Reporting Person's continuous service to the Issuer through such dates."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person is serving on the Board of the Issuer with the permission of RSJ."}],"balance_after":0,"derivative":{"exercise_price":7.91,"expiration_date":"2029-03-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-19-015669","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653967/000110465919015669/a4.xml","form_type":"4"}},{"id":3757957,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-11-20T22:56:42.000Z","date":"2018-10-08","kind":"disposition_to_issuer","acquired":false,"shares":144000,"price":1.38,"value":198720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 8, 2018, the Reporting Person was granted 144,000 shares of restricted common stock under the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan. The Reporting Person immediately and automatically assigned all benefits resulting from the October 8, 2018 grant of restricted common stock to RSJ Investments SICAV a.s. (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person is serving on the Board of MYnd Analytics, Inc. at the request of RSJ."},{"field":"shares","element":"transactionShares","label":"F1","text":"On October 8, 2018, the Reporting Person was granted 144,000 shares of restricted common stock under the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan. The Reporting Person immediately and automatically assigned all benefits resulting from the October 8, 2018 grant of restricted common stock to RSJ Investments SICAV a.s. (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person is serving on the Board of MYnd Analytics, Inc. at the request of RSJ."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"On October 8, 2018, the Reporting Person was granted 144,000 shares of restricted common stock under the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan. The Reporting Person immediately and automatically assigned all benefits resulting from the October 8, 2018 grant of restricted common stock to RSJ Investments SICAV a.s. (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person is serving on the Board of MYnd Analytics, Inc. at the request of RSJ."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001615774-18-013077","document":"s114147_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418013077/s114147_form4.xml","form_type":"4/A","original_submission_date":"2018-10-10"}},{"id":3757956,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-11-20T22:56:42.000Z","date":"2018-10-08","kind":"grant","acquired":true,"shares":144000,"price":1.38,"value":198720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 8, 2018, the Reporting Person was granted 144,000 shares of restricted common stock under the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan. The Reporting Person immediately and automatically assigned all benefits resulting from the October 8, 2018 grant of restricted common stock to RSJ Investments SICAV a.s. (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person is serving on the Board of MYnd Analytics, Inc. at the request of RSJ."},{"field":"shares","element":"transactionShares","label":"F1","text":"On October 8, 2018, the Reporting Person was granted 144,000 shares of restricted common stock under the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan. The Reporting Person immediately and automatically assigned all benefits resulting from the October 8, 2018 grant of restricted common stock to RSJ Investments SICAV a.s. (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person is serving on the Board of MYnd Analytics, Inc. at the request of RSJ."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"On October 8, 2018, the Reporting Person was granted 144,000 shares of restricted common stock under the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan. The Reporting Person immediately and automatically assigned all benefits resulting from the October 8, 2018 grant of restricted common stock to RSJ Investments SICAV a.s. (\"RSJ\") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person is serving on the Board of MYnd Analytics, Inc. at the request of RSJ."}],"balance_after":144000,"source":{"system":"sec-edgar","filing":"0001615774-18-013077","document":"s114147_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418013077/s114147_form4.xml","form_type":"4/A","original_submission_date":"2018-10-10"}},{"id":3793784,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":69499,"kind":"person","name":"Votruba Michal","position":1,"cik":"0001653967","reported_name":"Votruba Michal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-10-11T01:26:29.000Z","date":"2018-10-08","kind":"grant","acquired":true,"shares":144000,"price":1.38,"value":198720.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 8, 2018, the Reporting Person was granted 144,000 restricted shares under the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan. The Reporting Person has assigned all benefits resulting from the grant of restricted common stock and options to RSJ Investments SICAV a.s. acting in respect of its sub-fund (podfond) RSJ Gradus pod fond, RSJ Investments SICAV a.s."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On October 8, 2018, the Reporting Person was granted 144,000 restricted shares under the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan. The Reporting Person has assigned all benefits resulting from the grant of restricted common stock and options to RSJ Investments SICAV a.s. acting in respect of its sub-fund (podfond) RSJ Gradus pod fond, RSJ Investments SICAV a.s."}],"balance_after":144000,"source":{"system":"sec-edgar","filing":"0001615774-18-010703","document":"s113238_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418010703/s113238_form4.xml","form_type":"4"}}]}